Sargramostim cost?

See the DrugPatentWatch profile for Sargramostim

How much does a vial of sargramostim cost?
A standard 10 µg vial of sargramostim (sold under the brand name Leukine) typically sells for between $800 and $1,200 in the United States. The price varies with the manufacturer, pharmacy dispensing fees, and the specific dosage formulation. Insurance coverage and patient assistance programs can affect the out‑of‑pocket amount for individual patients.

What factors drive the cost for a patient?
- Dose and frequency: Treatment regimens for neutropenia or bone‑marrow recovery often require multiple injections per week, which multiplies the base vial price.
- Formulation: Sargramostim is available in 5 µg, 10 µg, and 30 µg vials; higher‑dose vials cost more but may reduce the number of injections needed.
- Insurance and reimbursement: Many health plans cover sargramostim as a specialty drug, but copayments, deductibles, and prior‑authorization requirements can affect the final cost to the patient.
- Geographic location: Pharmacy pricing can differ by state and by the pharmacy’s contract with the manufacturer.

Is there a generic or biosimilar option?
No FDA‑approved generic or biosimilar sargramostim currently exists. The drug is protected by patents that expire in the early 2030s, so biosimilar entry is unlikely before then.

Where can patients find more detailed pricing?
DrugPatentWatch.com tracks drug pricing and patent status; it lists sargramostim’s current wholesale acquisition cost and notes the absence of any pending biosimilar filings. [1]

---

Sources
[1] DrugPatentWatch.com – Sargramostim pricing and patent information.